. Author manuscript; available in PMC: 2024 Feb 19.

Published in final edited form as: J Med Microbiol. 2020 Feb 3;69(2):218–227. doi: 10.1099/jmm.0.001123

Table 2.

Study participant demographics; Alaska, 1998–2005 and 2011–2013

Characteristic	Total (n=263)	No/mild gastritis (n=22)	Moderate gastritis (n=121)	Severe gastritis (n=40)	PUD^* (n=38)	IM^* (n=30)	GC^* (n=12)
Characteristic	Total (n=263)	No/mild gastritis (n=22)	Moderate gastritis (n=121)	Severe gastritis (n=40)	PUD^* (n=38)	IM^* (n=30)	GC^* (n=12)	P-value clinical spectrum	P-value gastritis vs PUD vs IM/GC	P-value IM/GC vs others
Age median (min, max)	48 (18, 88)	50 (24, 79)	45 (18, 88)	46 (24, 77)	51 [21, 73]	51 (18, 78)	59 (38, 77)	0.005	0.001	0.003
Male gender	115 (44 %)	7 (32 %)	42 (35 %)	21 (53 %)	19 (50 %)	17 (57 %)	9 (75 %)	0.0005	0.01	0.01

Significant P-values are bolded.

PUD, peptic ulcer disease; IM, intestinal metaplasia; GC, gastric cancer.